Xencor, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 275.11M | 164.58M | 174.62M | 110.49M | 125.58M | 13.7% | |
| Cost of Revenue | (192.51M) | (199.56M) | — | (227.69M) | (10.51M) | -95.4% | |
Gross Profit | 82.60M | -34.98M | 174.62M | -117.19M | 115.06M | -198.2% | |
| Operating Expenses | |||||||
| Research & Development | (192.51M) | (199.56M) | (253.60M) | (227.69M) | (239.43M) | 5.2% | |
| Selling, General & Administrative | (38.84M) | (47.49M) | (53.38M) | (58.89M) | (63.64M) | 8.1% | |
| General & Administrative | (34.44M) | (40.40M) | (53.38M) | (50.09M) | (63.64M) | 27.1% | |
| Depreciation & Amortization | (7.49M) | (8.80M) | (11.50M) | (12.11M) | (10.51M) | -13.2% | |
Operating Income (EBIT) | 43.77M | -82.47M | -132.36M | -178.41M | -177.50M | -0.5% | |
| Non-Operating Items | |||||||
| Interest Income | 862.00K | 4.82M | 18.63M | 31.93M | 27.52M | -13.8% | |
| Interest Expense | (13.00K) | — | — | (36.64M) | (31.93M) | -12.9% | |
| Other Income/Expenses (Net) | 38.86M | 27.96M | 12.73M | -56.52M | 87.87M | -255.5% | |
Income Before Tax | 82.63M | -54.51M | -119.63M | -234.92M | -89.42M | -61.9% | |
| Income Tax Expense | — | (673.00K) | (13.66M) | (1.62M) | (2.50M) | 54.9% | |
Net Income | 82.63M | -55.18M | -133.13M | -232.62M | -91.92M | -60.5% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $1 | $-1 | $-2 | $-4 | $-1 | -65.4% | |
| Weighted Avg Shares Outstanding | 58.38M | 59.65M | 60.50M | 65.04M | 74.24M | 14.1% | |
| Weighted Avg Shares Outstanding (Diluted) | 60.50M | 59.65M | 60.50M | 65.04M | 74.24M | 14.1% | |
EBITDA | 90.14M | -45.70M | -101.96M | -186.17M | -46.98M | -74.8% |
Explore XNCR
XNCR in the Healthcare
Small Cap